Age, Biography and Wiki

Paul Schimmel was born on 4 August, 1940 in Hartford, Connecticut, is an American chemist. Discover Paul Schimmel's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 83 years old?

Popular As N/A
Occupation N/A
Age 83 years old
Zodiac Sign Leo
Born 4 August, 1940
Birthday 4 August
Birthplace Hartford, Connecticut
Nationality United States

We recommend you to check the complete list of Famous People born on 4 August. He is a member of famous with the age 83 years old group.

Paul Schimmel Height, Weight & Measurements

At 83 years old, Paul Schimmel height not available right now. We will update Paul Schimmel's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Paul Schimmel Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Paul Schimmel worth at the age of 83 years old? Paul Schimmel’s income source is mostly from being a successful . He is from United States. We have estimated Paul Schimmel's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Paul Schimmel Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1940

Paul Reinhard Schimmel (born August 4, 1940) is an American biophysical chemist and translational medicine pioneer.

Paul Schimmel is a Professor of Molecular Medicine at The Scripps Research Institute.

Prior to joining The Scripps Research Institute, he was a John D. and Catherine T. MacArthur Professor of Biochemistry and Biophysics at MIT (Massachusetts Institute of Technology).

Author or coauthor of many scientific research publications, he is also coauthor of a widely used 3-volume textbook on biophysical chemistry.

His research interests have focused on aminoacyl tRNA synthetases as fundamental interpreters of the genetic information.

Through career-long investigations of this ancient and universal set of essential enzymes, his laboratory has worked on a universal mechanism for correcting errors in the interpretation of genetic information, and went on to show how this mechanism is essential for maintaining cellular homeostasis and for preventing serious pathologies and disease.

1983

In a separate line of research published back in 1983, Schimmel developed the concept of what are now known as ESTs (expressed sequence tags) and the strategy of shotgun sequencing, approaches that several years later were adopted for the human genome project.

Nature magazine listed Schimmel's work on the development of ESTs as one of the four key developments that launched the human genome project.

Lastly, his laboratory established connections of synthetases to disease and, most recently, they reported the structural and functional metamorphosis of these proteins, whereby they are repurposed with novel activities, both inside and outside the cell, in a variety of cell signaling pathways

Named to various society and university awards and honorary degrees, and elected to membership in the American Academy of Arts and Sciences, the National Academy of Sciences, the American Philosophical Society, the Institute of Medicine (National Academy of Medicine) and National Academy of Inventors.

Active in many scientific and academic organizations and committees, including past service as President of the Division of Biological Chemistry of the American Chemical Society (presently with over 7,000 members) and as an editorial board member of numerous scientific journals.

2012

He has also been listed as one of the leading translational researchers in the world, having one of the top five most cited patents for the period 2012-2016.

His laboratory also discovered what others have referred to as a tRNA synthetase-directed primordial, or 'second', genetic code that eventually was incorporated into the modern code.

2020

In June 2020, he was named the 2020 winner of the Kathryn C. Hach Award for Entrepreneurial Success for "co-founding more than ten biotech companies and aiding others in their endeavors for nearly three decades."

Named the ARCS San Diego Chapter 2020 Scientist of the Year